Arrowhead Pharmaceuticals Inc (ARWR)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: ARWR Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2023-01-05 2023-01-03 PS Planned sale

Hamilton James C

Chief Discovery/Trans Medicine
300 -0.2%
39.74
11,922 USD 		300 -0.2% 39.74 11,922 USD
2023-01-05 2023-01-03 PS Planned sale

Hamilton James C

Chief Discovery/Trans Medicine
2,837 -1.8%
38.53
109,310 USD 		2,837 -1.8% 38.53 109,310 USD
2023-01-05 2023-01-03 PS Planned sale

Hamilton James C

Chief Discovery/Trans Medicine
1,194 -0.8%
37.46
44,727 USD 		1,194 -0.8% 37.46 44,727 USD
2022-12-30 2022-12-29 PS Planned sale

Myszkowski Kenneth Allen

Chief Financial Officer

Officer
30,625 -8.3%
40.00
1,225,000 USD 		30,625 -8.3% 40.00 1,225,000 USD
2022-11-22 2022-11-21 PS Planned sale

San Martin Javier

Chief Medical Officer

Officer
200 -0.2%
30.62
6,124 USD 		200 -0.2% 30.62 6,124 USD
2022-11-22 2022-11-21 PS Planned sale

San Martin Javier

Chief Medical Officer

Officer
19,300 -17.4%
29.98
578,614 USD 		19,300 -17.4% 29.98 578,614 USD
2022-02-14 2022-02-11 PS Planned sale

Anzalone Christopher Richard

Chief Executive Officer

Executive Director
1,900 -0.0%
50.51
95,969 USD 		1,900 -0.0% 50.51 95,969 USD
2022-02-14 2022-02-11 PS Planned sale

Anzalone Christopher Richard

Chief Executive Officer

Executive Director
61,482 -1.5%
50.90
3,129,434 USD 		61,482 -1.5% 50.90 3,129,434 USD
2022-02-14 2022-02-11 PS Planned sale

Anzalone Christopher Richard

Chief Executive Officer

Executive Director
42,153 -1.0%
52.28
2,203,759 USD 		42,153 -1.0% 52.28 2,203,759 USD
2022-02-14 2022-02-11 PS Planned sale

Anzalone Christopher Richard

Chief Executive Officer

Executive Director
40,853 -1.0%
53.11
2,169,703 USD 		40,853 -1.0% 53.11 2,169,703 USD
2022-01-07 2022-01-05 PS Planned sale

O'Brien Patrick

General Counsel

Officer
316 -0.1%
64.35
20,335 USD 		316 -0.1% 64.35 20,335 USD
2022-01-07 2022-01-05 PS Planned sale

O'Brien Patrick

General Counsel

Officer
4,400 -1.2%
63.75
280,500 USD 		4,400 -1.2% 63.75 280,500 USD
2022-01-07 2022-01-05 PS Planned sale

O'Brien Patrick

General Counsel

Officer
5,000 -1.4%
62.49
312,450 USD 		5,000 -1.4% 62.49 312,450 USD
2022-01-07 2022-01-05 PS Planned sale

O'Brien Patrick

General Counsel

Officer
10,350 -2.8%
61.88
640,458 USD 		10,350 -2.8% 61.88 640,458 USD
2022-01-07 2022-01-05 PS Planned sale

O'Brien Patrick

General Counsel

Officer
12,434 -3.3%
60.49
752,133 USD 		12,434 -3.3% 60.49 752,133 USD
2022-01-06 2022-01-05 PS Planned sale

Hamilton James C

Senior Vice President
60 -0.0%
64.35
3,861 USD 		60 -0.0% 64.35 3,861 USD
2022-01-06 2022-01-05 PS Planned sale

Hamilton James C

Senior Vice President
700 -0.4%
63.68
44,576 USD 		700 -0.4% 63.68 44,576 USD
2022-01-06 2022-01-05 PS Planned sale

Hamilton James C

Senior Vice President
1,100 -0.7%
62.64
68,904 USD 		1,100 -0.7% 62.64 68,904 USD
2022-01-06 2022-01-05 PS Planned sale

Hamilton James C

Senior Vice President
2,100 -1.3%
61.84
129,864 USD 		2,100 -1.3% 61.84 129,864 USD
2022-01-06 2022-01-05 PS Planned sale

Hamilton James C

Senior Vice President
2,290 -1.4%
60.51
138,568 USD 		2,290 -1.4% 60.51 138,568 USD
2022-01-06 2022-01-05 PS Planned sale

Myszkowski Kenneth Allen

Chief Financial Officer

Officer
3,786 -0.8%
63.95
242,115 USD 		3,786 -0.8% 63.95 242,115 USD
2022-01-06 2022-01-05 PS Planned sale

Myszkowski Kenneth Allen

Chief Financial Officer

Officer
3,778 -0.8%
63.17
238,656 USD 		3,778 -0.8% 63.17 238,656 USD
2022-01-06 2022-01-05 PS Planned sale

Myszkowski Kenneth Allen

Chief Financial Officer

Officer
16,528 -3.4%
62.00
1,024,736 USD 		16,528 -3.4% 62.00 1,024,736 USD
2022-01-06 2022-01-05 PS Planned sale

Myszkowski Kenneth Allen

Chief Financial Officer

Officer
15,908 -3.2%
60.50
962,434 USD 		15,908 -3.2% 60.50 962,434 USD
2022-01-06 2022-01-04 PS Planned sale

Hamilton James C

Senior Vice President
500 -0.3%
69.38
34,690 USD 		500 -0.3% 69.38 34,690 USD
2022-01-06 2022-01-04 PS Planned sale

Hamilton James C

Senior Vice President
649 -0.4%
68.12
44,210 USD 		649 -0.4% 68.12 44,210 USD
2022-01-06 2022-01-04 PS Planned sale

Hamilton James C

Senior Vice President
802 -0.5%
67.39
54,047 USD 		802 -0.5% 67.39 54,047 USD
2022-01-06 2022-01-04 PS Planned sale

Hamilton James C

Senior Vice President
7,469 -4.4%
65.59
489,892 USD 		7,469 -4.4% 65.59 489,892 USD
2022-01-06 2022-01-04 PS Planned sale

Hamilton James C

Senior Vice President
9,955 -5.5%
64.89
645,980 USD 		9,955 -5.5% 64.89 645,980 USD
2022-01-04 2022-01-03 PS Planned sale

OLUKOTUN ADEOYE Y

Non-Executive Director
244 -4.7%
66.25
16,165 USD 		244 -4.7% 66.25 16,165 USD
2022-01-04 2022-01-03 PS Planned sale

OLUKOTUN ADEOYE Y

Non-Executive Director
1,916 -26.9%
65.04
124,617 USD 		1,916 -26.9% 65.04 124,617 USD
2022-01-04 2022-01-03 PS Planned sale

OLUKOTUN ADEOYE Y

Non-Executive Director
1,890 -21.0%
64.26
121,451 USD 		1,890 -21.0% 64.26 121,451 USD
2022-01-04 2022-01-03 PS Planned sale

PERRY MICHAEL S

Non-Executive Director
272 -0.3%
66.25
18,020 USD 		272 -0.3% 66.25 18,020 USD
2022-01-04 2022-01-03 PS Planned sale

PERRY MICHAEL S

Non-Executive Director
1,600 -1.8%
65.12
104,192 USD 		1,600 -1.8% 65.12 104,192 USD
2022-01-04 2022-01-03 PS Planned sale

PERRY MICHAEL S

Non-Executive Director
2,628 -2.9%
64.30
168,980 USD 		2,628 -2.9% 64.30 168,980 USD
2022-01-04 2022-01-03 S Sale

De Backer Marianne

Non-Executive Director
272 -1.6%
66.25
18,020 USD 		272 -1.6% 66.25 18,020 USD
2022-01-04 2022-01-03 S Sale

De Backer Marianne

Non-Executive Director
1,984 -10.3%
65.01
128,980 USD 		1,984 -10.3% 65.01 128,980 USD
2022-01-04 2022-01-03 S Sale

De Backer Marianne

Non-Executive Director
2,244 -10.4%
64.25
144,177 USD 		2,244 -10.4% 64.25 144,177 USD
2022-01-04 2022-01-03 PS Planned sale

Waddill William D.

Non-Executive Director
272 -1.0%
66.25
18,020 USD 		272 -1.0% 66.25 18,020 USD
2022-01-04 2022-01-03 PS Planned sale

Waddill William D.

Non-Executive Director
2,128 -7.6%
65.01
138,341 USD 		2,128 -7.6% 65.01 138,341 USD
2022-01-04 2022-01-03 PS Planned sale

Waddill William D.

Non-Executive Director
2,100 -6.9%
64.23
134,883 USD 		2,100 -6.9% 64.23 134,883 USD
2021-12-17 2021-12-15 PS Planned sale

Anzalone Christopher Richard

Chief Executive Officer

Executive Director
6,989 -0.2%
70.19
490,558 USD 		6,989 -0.2% 70.19 490,558 USD
2021-12-17 2021-12-15 PS Planned sale

Anzalone Christopher Richard

Chief Executive Officer

Executive Director
9,223 -0.3%
69.52
641,183 USD 		9,223 -0.3% 69.52 641,183 USD
2021-12-17 2021-12-15 PS Planned sale

Anzalone Christopher Richard

Chief Executive Officer

Executive Director
3,074 -0.1%
68.20
209,647 USD 		3,074 -0.1% 68.20 209,647 USD
2021-12-17 2021-12-15 PS Planned sale

Anzalone Christopher Richard

Chief Executive Officer

Executive Director
14,857 -0.5%
67.19
998,242 USD 		14,857 -0.5% 67.19 998,242 USD
2021-12-17 2021-12-15 PS Planned sale

Anzalone Christopher Richard

Chief Executive Officer

Executive Director
25,857 -0.8%
66.28
1,713,802 USD 		25,857 -0.8% 66.28 1,713,802 USD
2021-11-22 2021-11-19 PS Planned sale

San Martin Javier

Chief Medical Officer

Officer
100 -0.1%
70.99
7,099 USD 		100 -0.1% 70.99 7,099 USD
2021-11-22 2021-11-19 PS Planned sale

San Martin Javier

Chief Medical Officer

Officer
5,696 -4.9%
70.01
398,777 USD 		5,696 -4.9% 70.01 398,777 USD
2021-11-22 2021-11-19 PS Planned sale

San Martin Javier

Chief Medical Officer

Officer
13,704 -10.5%
69.01
945,713 USD 		13,704 -10.5% 69.01 945,713 USD
2021-10-22 2021-10-22 PS Planned sale

Anzalone Christopher Richard

Chief Executive Officer

Executive Director
5,830 -0.2%
66.09
385,305 USD 		5,830 -0.2% 66.09 385,305 USD
2021-10-22 2021-10-22 PS Planned sale

Anzalone Christopher Richard

Chief Executive Officer

Executive Director
44,170 -1.3%
65.57
2,896,227 USD 		44,170 -1.3% 65.57 2,896,227 USD
2021-10-22 2021-10-20 PS Planned sale

Anzalone Christopher Richard

Chief Executive Officer

Executive Director
15,000 -0.4%
66.23
993,450 USD 		15,000 -0.4% 66.23 993,450 USD
2021-09-14 2021-09-13 S Sale

OLUKOTUN ADEOYE Y

Non-Executive Director
2,750 -23.4%
63.76
175,340 USD 		2,750 -23.4% 63.76 175,340 USD
2021-09-14 2021-09-13 PS Planned sale

OLUKOTUN ADEOYE Y

Non-Executive Director
2,250 -16.1%
63.76
143,460 USD 		2,250 -16.1% 63.76 143,460 USD
2021-06-25 2021-06-24 S Sale

De Backer Marianne

Non-Executive Director
5,000 -18.9%
89.85
449,250 USD 		5,000 -18.9% 89.85 449,250 USD
2021-06-24 2021-06-22 S Sale

GIVEN DOUGLAS B

Non-Executive Director
4,500 -3.8%
89.21
401,445 USD 		4,500 -3.8% 89.21 401,445 USD
2021-06-24 2021-06-22 S Sale

Hassard James

Chief Commercial Officer

Officer
3,625 -3.3%
89.22
323,423 USD 		3,625 -3.3% 89.22 323,423 USD
2021-02-24 2021-02-22 S Sale

GIVEN DOUGLAS B

Non-Executive Director
1,125 -7.5%
88.73
99,821 USD 		1,125 -7.5% 88.73 99,821 USD
2021-02-10 2021-02-08 S Sale

O'Brien Patrick

General Counsel

Officer
5,436 -1.8%
89.66
487,392 USD 		5,436 -1.8% 89.66 487,392 USD
2021-02-10 2021-02-08 S Sale

O'Brien Patrick

General Counsel

Officer
45,348 -13.2%
88.88
4,030,530 USD 		45,348 -13.2% 88.88 4,030,530 USD
2021-02-10 2021-02-08 S Sale

O'Brien Patrick

General Counsel

Officer
31,255 -8.3%
88.08
2,752,940 USD 		31,255 -8.3% 88.08 2,752,940 USD
2021-02-10 2021-02-08 S Sale

O'Brien Patrick

General Counsel

Officer
7,961 -2.1%
86.72
690,378 USD 		7,961 -2.1% 86.72 690,378 USD
2021-01-19 2021-01-15 S Sale

GIVEN DOUGLAS B

Non-Executive Director
3,000 -19.4%
83.28
249,840 USD 		3,000 -19.4% 83.28 249,840 USD
2021-01-15 2021-01-14 S Sale

Hamilton James C

Senior Vice President
3,814 -2.9%
81.82
312,061 USD 		3,814 -2.9% 81.82 312,061 USD
2021-01-15 2021-01-14 S Sale

Hamilton James C

Senior Vice President
6,186 -4.5%
80.97
500,880 USD 		6,186 -4.5% 80.97 500,880 USD
2021-01-12 2021-01-12 S Sale

Myszkowski Kenneth Allen

Chief Financial Officer

Officer
1,441 -0.3%
81.00
116,721 USD 		1,441 -0.3% 81.00 116,721 USD
2021-01-12 2021-01-11 S Sale

Myszkowski Kenneth Allen

Chief Financial Officer

Officer
11,597 -2.5%
81.02
939,589 USD 		11,597 -2.5% 81.02 939,589 USD
2021-01-08 2021-01-07 PS Planned sale

Hassard James

Chief Commercial Officer

Officer
15,625 -12.5%
75.00
1,171,875 USD 		15,625 -12.5% 75.00 1,171,875 USD
2021-01-07 2021-01-06 PS Planned sale

Hamilton James C

Senior Vice President
14,708 -9.7%
72.67
1,068,830 USD 		14,708 -9.7% 72.67 1,068,830 USD
2021-01-07 2021-01-06 PS Planned sale

Hamilton James C

Senior Vice President
3,967 -2.6%
72.05
285,822 USD 		3,967 -2.6% 72.05 285,822 USD
2021-01-07 2021-01-06 PS Planned sale

Hamilton James C

Senior Vice President
700 -0.4%
70.89
49,623 USD 		700 -0.4% 70.89 49,623 USD
2021-01-07 2021-01-06 PS Planned sale

Myszkowski Kenneth Allen

Chief Financial Officer

Officer
25,166 -5.2%
72.63
1,827,807 USD 		25,166 -5.2% 72.63 1,827,807 USD
2021-01-07 2021-01-06 PS Planned sale

Myszkowski Kenneth Allen

Chief Financial Officer

Officer
4,359 -0.9%
71.77
312,845 USD 		4,359 -0.9% 71.77 312,845 USD
2021-01-07 2021-01-06 PS Planned sale

O'Brien Patrick

General Counsel

Officer
13,243 -4.3%
72.67
962,369 USD 		13,243 -4.3% 72.67 962,369 USD
2021-01-07 2021-01-06 PS Planned sale

O'Brien Patrick

General Counsel

Officer
10,615 -3.3%
72.27
767,146 USD 		10,615 -3.3% 72.27 767,146 USD